EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Key Challenges in Screening Blood Donors for Hepatitis B Virus

Maha A Badawi iD, Sahar Eldakhakhny iD, Mohamed Ali iD, Mazen Badawi iD, Jaffar Khiariy, Yagoub Bin-Taleb iD, Salwa I Hindawi iD

Viruses · 2025

DOI: 10.3390/v18010023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Maha A Badawi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Hepatitis B virus, Blood Donors, Hepatitis B, Donor Selection. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Laboratories GmBH, Abbott.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Technological advancements in blood donor screening have significantly improved blood safety. However, certain testing challenges and limitations continue to face blood banks in donor screening for the hepatitis B virus, resulting in occasional cases of transfusion transmission. These cases are mostly related to donors presenting within the window period and donors with occult hepatitis B infection. There are several other challenges that professionals in transfusion medicine, infectious diseases, gastroenterology, and public health must be aware of. Maintaining the highest test sensitivity is a key parameter for enhancing blood safety, and the review describes current recommendations in this regard, along with relevant advancements. The diversity of viral genotypes and the potential for mutations affecting the surface antigen may negatively affect the performance of both serologic and nucleic acid tests. Serologic tests may also be affected by several interferences, endogenous or exogenous to the sample. A clear understanding of these challenges is necessary to create effective policies and procedures and to properly manage atypical cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusBlood DonorsHepatitis BDonor SelectionMass ScreeningHumansBlood DonationGenotype

Stichwörter der Autor:innen

blood donationdonor screeninghepatitis B virus

Autor:innen und Institutionen

  • Hematology Department, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Hematology Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Blood Transfusion Services Unit, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia.
  • Diagnostic Virology Laboratory, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia.
  • Abbott Laboratories GmbH, Dubai P.O. Box 32002, United Arab Emirates.
  • Infectious Diseases Division, Internal Medicine Department, King Faisal Specialist Hospital and Research Centre, Jeddah 21499, Saudi Arabia.

ORCID-Profile: Maha A Badawi, Sahar Eldakhakhny, Mohamed Ali, Mazen Badawi, Yagoub Bin-Taleb, Salwa I Hindawi

Förderung

  • Abbott Laboratories GmBH
  • Abbott

Zitieren

APA

Badawi, M. A., Eldakhakhny, S., Ali, M., Badawi, M., Khiariy, J., Bin-Taleb, Y., & Hindawi, S. I. (2025). Key Challenges in Screening Blood Donors for Hepatitis B Virus. Viruses. https://doi.org/10.3390/v18010023

Vancouver

Badawi MA, Eldakhakhny S, Ali M, Badawi M, Khiariy J, Bin-Taleb Y, et al. Key Challenges in Screening Blood Donors for Hepatitis B Virus. Viruses. 2025. doi:10.3390/v18010023

BibTeX
@article{Badawi2025,
  author = {Badawi, Maha A and Eldakhakhny, Sahar and Ali, Mohamed and Badawi, Mazen and Khiariy, Jaffar and Bin-Taleb, Yagoub and Hindawi, Salwa I},
  title = {Key Challenges in Screening Blood Donors for Hepatitis B Virus},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v18010023}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche